Literature DB >> 12127682

P301L tauopathy: confocal immunofluorescence study of perinuclear aggregation of the mutated protein.

Emil Adamec1, Jill R Murrell, Masaki Takao, Wendy Hobbs, Ralph A Nixon, Bernardino Ghetti, Jean P Vonsattel.   

Abstract

The clinical and neuropathological features in the P301L tauopathy have been described in several kindreds. In this study, we present findings in two previously unreported patients, evaluated both genetically, neuropathologically, and with multiparametric confocal immunofluorescence. The patients were female, with age 65 and 75 years old, respectively. Both exhibited clinical symptoms of frontotemporal dementia (FTD). Marked atrophy of the frontal and temporal lobes with moderate atrophy of the remaining cerebral and brain stem structures was present. The substantia nigra was pale. The atrophic neocortical regions exhibited neuronal loss, marked gliosis, status spongiosus, and occasional ballooned neurons. By light microscopy, the most striking findings were argyrophilic perinuclear rings, frequently with an attached small inclusion (mini Pick-like body), especially prominent in dentate granule cells, entorhinal and temporal cortices, and to a lesser extent in CA1. These structures were immunopositive for tau protein (Tau-2, AT-8, PHF-1, MC-1). Numerous astrocytic plaques, tuft-shaped astrocytes, coiled bodies, and dystrophic neurites were also present. Confocal immunofluorescence with a P301L-specific antibody directly demonstrated the presence of the mutated protein in the PHF-1 positive aggregates. The mutated tau protein (4-repeat tau) was detected in the mini Pick-like bodies, indicating an important biochemical difference between these inclusions and classical Pick bodies (3-repeat tau). Additionally, since 4-repeat tau protein is not normally present in dentate granule cells, this result also suggests an abnormality in the mRNA splicing mechanisms. The structural features of the involvement of proteolytic systems in this tauopathy were assessed by immunohistochemistry for the active form of calpain II (C-27) and ubiquitin. Colocalization of PHF-1 positive aggregates with C-27 points to the possible involvement of calpain in tau protein hyperphosphorylation. Absence of immunostaining for ubiquitin indicates possible dysfunction of the ubiquitin-proteasome system in this tauopathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127682     DOI: 10.1016/s0022-510x(02)00150-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.

Authors:  P Tacik; M Sanchez-Contreras; M DeTure; M E Murray; R Rademakers; O A Ross; Z K Wszolek; J E Parisi; D S Knopman; R C Petersen; D W Dickson
Journal:  Neuropathol Appl Neurobiol       Date:  2017-03-08       Impact factor: 8.090

2.  The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration.

Authors:  So-Young Park; Adriana Ferreira
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

Review 3.  The Role of Extracellular Matrix Components in the Spreading of Pathological Protein Aggregates.

Authors:  Edoardo Moretto; Skye Stuart; Sunaina Surana; Jose Norberto S Vargas; Giampietro Schiavo
Journal:  Front Cell Neurosci       Date:  2022-04-29       Impact factor: 6.147

4.  Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease.

Authors:  Takahide Kaji; Barry Boland; Tatjana Odrljin; Panaiyur Mohan; Balapal S Basavarajappa; Corrinne Peterhoff; Anne Cataldo; Anna Rudnicki; Niranjana Amin; Bing Sheng Li; Harish C Pant; Basalingappa L Hungund; Ottavio Arancio; Ralph A Nixon
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

5.  NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation.

Authors:  Giuseppina Amadoro; Maria Teresa Ciotti; Marco Costanzi; Vincenzo Cestari; Pietro Calissano; Nadia Canu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

6.  Adult-onset focal expression of mutated human tau in the hippocampus impairs spatial working memory of rats.

Authors:  Martina L Mustroph; Michael A King; Ronald L Klein; Julio J Ramirez
Journal:  Behav Brain Res       Date:  2012-04-25       Impact factor: 3.332

7.  Implicating calpain in tau-mediated toxicity in vivo.

Authors:  James B Reinecke; Sarah L DeVos; James P McGrath; Amanda M Shepard; Dustin K Goncharoff; Don N Tait; Samantha R Fleming; Michael P Vincent; Michelle L Steinhilb
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.